AGE-BASED (<65 VS ≥65 YEARS) INCIDENCE OF INFECTIONS AND SERIOUS INFECTIONS IN TOFACITINIB-, ADALIMUMAB- AND PLACEBO-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, PHASE 3 AND PHASE 3B/4 TOFACITINIB STUDIES

被引：1
|
作者：
Winthrop, K. [1 ]
Gold, D. [2 ]
Henrohn, D. [3 ]
Wang, L. [4 ]
Shapiro, A. [5 ]
Shi, H. [6 ]
Citera, G. [7 ]
Schulze-Koops, H. [8 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Pfizer Inc, Montreal, PQ, Canada
[3] Pfizer Inc, Sollentuna, Sweden
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Pfizer Inc, Peapack, NJ USA
[6] Pfizer Inc, Collegeville, PA USA
[7] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina
[8] Klinikum Univ Munchen, Munich, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.1432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0139
引用
收藏
页码：1003 / 1004
页数：2
相关论文
共 32 条
  • [1] Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry
    Winthrop, Kevin L.
    Citera, Gustavo
    Gold, David
    Henrohn, Dan
    Connell, Carol A.
    Shapiro, Andrea B.
    Shi, Harry
    Onofrei, Alina M.
    Pappas, Dimitrios A.
    Schulze-Koops, Hendrik
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (01) : 134 - 136
  • [2] Tofacitinib in Patients with Rheumatoid Arthritis and Indicative of Depression And/or Anxiety: A Post Hoc Analysis of Phase 3 and Phase 3b/4 Clinical Trials
    Citera, Gustavo
    Jain, Rakesh
    Irazoque, Fedra
    Guzman, Renato
    Madariaga, Hugo
    Gruben, David
    Wang, Lisy
    Stockert, Lori
    Hsu, Ming-Ann
    Santana, Karina
    Ebrahim, Abbas
    Ponce de Leon, Dario
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INDICATIVE OF DEPRESSION AND/OR ANXIETY: A POST HOC ANALYSIS OF PHASE 3 AND PHASE 3B/4 CLINICAL TRIALS
    Citera, G.
    Jain, R.
    Irazoque-Palazuelos, F.
    Guzman, R.
    Madariaga, H.
    Gruben, D. C.
    Wang, L.
    Stockert, L.
    Hsu, M. A.
    Santana, K.
    Ebrahim, A.
    Ponce de Leon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 314 - 315
  • [4] Impact of Sociodemographic Factors on Efficacy and Safety of Tofacitinib in Patients with Rheumatoid Arthritis: A Post Hoc Analysis of Phase 2/3/3b/4 Studies
    Wright, Grace
    Mysler, Eduardo
    Roberts, Kevin
    Sweet, Lindsay
    Shelbaya, Ahmed
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4172 - 4175
  • [5] TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND CO-OCCURRENCE OF DEPRESSION AND/OR ANXIETY: A POST HOC ANALYSIS OF PHASE 3 AND PHASE 3B/4 CLINICAL TRIALS
    Citera, Gustavo
    Jain, Rakesh
    Irazoque, Fedra
    Guzman, Renato
    Madariaga, Hugo
    Gruben, David
    Wang, Lisy
    Stockert, Lori
    Hsu, Ming-Ann
    Santana, Karina
    Ebrahim, Abbas
    Ponce de Leon, Dario
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 6 - 6
  • [6] IMPACT OF RACE ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, 3 AND 3B/4 CLINICAL TRIALS
    Wright, G. C.
    Mysler, E.
    Chen, Y. H.
    Kinch, C.
    Yndestad, A.
    Kwok, K.
    Cadatal, M. J.
    Germino, R.
    Ogdie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 609 - 609
  • [7] PAIN REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB MONOTHERAPY WITH OR WITHOUT PAIN MEDICATION: A POST HOC ANALYSIS OF POOLED DATA FROM PHASE 2, PHASE 3 AND PHASE 3B/4 STUDIES
    Taylor, Peter C.
    van de Laar, Mart
    Curtis, Jeffrey R.
    Azevedo, Valderilio F.
    Luis Rivas, Jose
    Dahl, Palle
    Wang, Lisy
    Iikuni, Noriko
    Shi, Harry
    Woolcott, John
    Benkhalifa, Salim
    Gomez-Reino, Juan Jose
    Dougados, Maxime
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1687 - 1688
  • [8] Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
    Citera, Gustavo
    Jain, Rakesh
    Irazoque, Fedra
    Madariaga, Hugo
    Gruben, David
    Wang, Lisy
    Stockert, Lori
    Santana, Karina
    Ebrahim, Abbas
    Ponce de Leon, Dario
    RHEUMATOLOGY AND THERAPY, 2024, 11 (01) : 35 - 50
  • [9] Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
    Gustavo Citera
    Rakesh Jain
    Fedra Irazoque
    Hugo Madariaga
    David Gruben
    Lisy Wang
    Lori Stockert
    Karina Santana
    Abbas Ebrahim
    Dario Ponce de Leon
    Rheumatology and Therapy, 2024, 11 : 35 - 50
  • [10] EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO DURATION OF PRIOR CSDMARD TREATMENT AND NUMBER OF PRIOR CSDMARDS: A POST HOC ANALYSIS OF PHASE 3 AND PHASE 3B/4 TRIALS
    Aletaha, Daniel
    Gomez-Reino, Juan Jose
    Burmester, Gerd Rudiger
    van Vollenhoven, Ronald
    Luis Rivas, Jose
    Benkhalifa, Salim
    Dahl, Palle
    Shi, Harry
    Wang, Lisy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1671 - 1672
1234